
Biomolecules, Journal Year: 2025, Volume and Issue: 15(4), P. 598 - 598
Published: April 17, 2025
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that play crucial role in extracellular matrix (ECM) remodeling and implicated the pathogenesis various cardiovascular diseases (CVDs). Their dysregulation has been linked to atherosclerosis, myocardial infarction (MI), heart failure (HF), aortic stenosis, contributing vascular inflammation, plaque destabilization, adverse cardiac remodeling. Recent research highlights MMPs’ involvement beyond ECM degradation, influencing lipoprotein metabolism, inflammatory signaling, intracellular processes critical for homeostasis. Despite their pathological role, MMPs remain promising therapeutic targets, with pharmacological inhibitors, gene therapy, tissue inhibitors (TIMPs) emerging as potential interventions. However, clinical translation MMP-targeting therapies remains challenging due off-target effects complex regulatory mechanisms. This review provides an updated synthesis molecular mechanisms, disease-specific roles, implications pathology, aiming bridge gap between fundamental applications.
Language: Английский